Digital Transformation

Tempus AI's research at a key symposium shows its AI-driven edge, turning vast patient data into a powerful asset that could reshape oncology and investor outlooks.

EPAM and Google Cloud are moving beyond general AI, launching seven production-ready agents designed to solve specific, complex industry problems.

A new project blends blockchain and next-gen security protocols to build a sovereign internet, fortifying Canada's Arctic defense and digital independence.

A fierce bidding war for Avadel Pharmaceuticals reveals the high value of its key drug, as filings from giants like State Street highlight M&A transparency.

After a financial tightrope walk, Actelis Networks is back in Nasdaq's good graces. But the real story is its mission to secure our future's IoT.

AskBio's gene therapies for Parkinson's and heart failure have received Japan's SAKIGAKE designation, promising a faster path to patients.

A partnership between ZEDEDA and Sonny's Enterprises reveals how edge orchestration is transforming traditional industry and creating a blueprint for the future.

One agency's breakout year reveals a critical lesson: strategic AI adoption is no longer optional. Discover the framework for moving beyond hype to ROI.

Dr. Timothy Lubenow's move from a top university to a community clinic highlights a trend that's making advanced medical care more accessible.

Animal health giant Elanco is restructuring its global footprint, betting its future on a U.S.-centric innovation pipeline and blockbuster pet health drugs.

OutSystems' #1 G2 ranking isn't just an award; it signals a seismic shift where AI-powered low-code and user satisfaction are the new currencies.

TransAlta is converting a massive coal plant to natural gas, a pragmatic yet controversial move in the push for a cleaner, reliable energy future.

Beyond the award, Pariveda's use of generative AI to modernize legacy systems reveals a powerful new playbook for enterprise transformation and value.

With its new 'Eagle Line' pilot facility online, QuantumScape takes a leap toward the EV future. We analyze the tech, the risks, and the competition.

With validated Phase 1b data, ONL Therapeutics' novel drug aims to protect vision cells, not just slow disease, in a challenge to current GA therapies.

Once mired in debt, Castellum has secured over $170M in prime contracts, signaling a dramatic resurgence in the competitive federal defense market.

A quiet investment in a communication platform is making a loud statement about the future of work and education. Here’s why it matters for your brand.

How the world's largest Catholic media network leveraged its global infrastructure to turn a grassroots prayer event into a worldwide phenomenon.

A Chinese city is investing in a new tourism model, blending adrenaline sports and ancient culture to capture a lucrative youth market. A strategic play.

Granted a tight deadline by Nasdaq, Triller Group must fix its finances and failing stock price or face delisting. Is its hybrid social media-fintech model viable?